ArticleNPJ digital medicine2026
Smartphone-based detection of subtle memory decline in prodromal Alzheimer's disease.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The slow progression of Alzheimer's disease (AD) poses a challenge for the quantification of early disease-driven cognitive decline. Here, we show that frequently administered remote and unsupervised digital cognitive assessments can detect differences in cognitive decline within 30 weeks in early AD. The sample comprised 202 individuals (52-85 years old) recruited from longitudinal observational studies, who were cognitively unimpaired (CU, n = 152) or had a diagnosis of mild cognitive impairment (MCI, n = 50). Participants self-administered remote tasks testing memory precision for objects and scenes, associative memory, and familiarity-dependent memory. The MCI group showed greater decline than the CU group in the familiarity-dependent task, while stratifying the MCI group by beta-amyloid (Aβ) status (n = 21 Aβ-; n = 24 Aβ+) revealed greater change in memory precision for objects and familiarity-dependent memory in the MCI Aβ+ group. A 30-week change in the remote familiarity-dependent task was correlated with a multi-year change in annual in-person neuropsychological assessments. In conclusion, frequent remote cognitive testing is a promising tool to feasibly capture and monitor subtle and short-term cognitive decline.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.